ResearcherGuangzhou First People's HospitalActive in the last 2 years

Xiaofeng Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0650-4800; OpenAlex author ID A5140197270. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis. Last author DOI 10.1111/jcmm.71230 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dan Su · 1 shared paper, 2026 · strength 0.29
- Paper circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis. DOI 10.1111/jcmm.71230 ↗
Leyi Huang · 1 shared paper, 2026 · strength 0.29
- Paper circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis. DOI 10.1111/jcmm.71230 ↗
Quanbo Zhou · 1 shared paper, 2026 · strength 0.29
- Paper circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis. DOI 10.1111/jcmm.71230 ↗
Rihua He · 1 shared paper, 2026 · strength 0.29
- Paper circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis. DOI 10.1111/jcmm.71230 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.